More unhealthy news for the drug biz

Article

These aren't happy times for the pharmaceutical industry. Day by day, bad news accumulates, and even the Pharmaceutical Research and Manufacturers Association (PhRMA), the industry's trade organization, acknowledges that something has to give:

Recent Videos
Geetika Kennady, MD, FAAP
Jillian Cotter, MD
Jesse Hinckley, MD, PhD
Validating digital stethoscope for pediatric breath sounds, with Jennifer Nestor, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Sensory play for children with autism, with Joshua Feder, MD
Stephanie Chao, MD
Feasibility of ambulatory blood pressure monitoring in primary care | Carissa Baker-Smith, MD, MPH
Tina Tan, MD
Camille Walker CPNP-PC, MSN, CPNP Sacheen D. Harris MSN, CPNP-PC
Related Content
RSV prophylaxis: Palivizumab, nirsevimab, and more | Image Credit: © John Doe - © John Doe - stock.adobe.com.

RSV prophylaxis: Palivizumab, nirsevimab, and more

Noah Christian, MD;Joseph M. Collaco, MD, PhD
May 6th 2025
Article

Current prevention strategies include 2 injectables for infants and young children, namely palivizumab and nirsevimab.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Joshua Feder, MD

Joshua Feder, MD, on broadening the role of sensory integration in psychiatry

Joshua Feder, MD
May 5th 2025
Article

Joshua Feder, MD, highlights the need for psychiatry to better integrate sensory processing research into care strategies beyond autism.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Expert discussions from the 2025 Pediatric Academic Societies meeting

Expert discussions from the 2025 Pediatric Academic Societies meeting

Joshua Fitch, Senior Editor
May 2nd 2025
Article

Watch some of our top clips from a number of discussions with experts who presented at PAS 2025.

Mona Shahriari, MD previews Revolutionizing Atopic Dermatitis 2025

Mona Shahriari, MD previews Revolutionizing Atopic Dermatitis 2025

Mona Shahriari, MD, FAAD
May 2nd 2025
Article

Mona Shahriari, MD, discusses how RAD 2025 can equip providers with tools to improve atopic dermatitis outcomes.

© 2025 MJH Life Sciences

All rights reserved.